首页> 外文期刊>Carbohydrate Polymers: Scientific and Technological Aspects of Industrially Important Polysaccharides >Sodium alginate as a potential carrier in solid dispersion formulations to enhance dissolution rate and apparent water solubility of BCS II drugs
【24h】

Sodium alginate as a potential carrier in solid dispersion formulations to enhance dissolution rate and apparent water solubility of BCS II drugs

机译:海藻酸钠作为固体分散体制剂中的潜在载体,可提高BCS II药物的溶出度和表观水溶性

获取原文
获取原文并翻译 | 示例
           

摘要

The solid dispersion technique is the most effective method for improving the dissolution rate of poorly water-soluble drugs, however it depends on a suitable carrier selection. The work explored the use of the biopolymer sodium alginate (SA) as a potential carrier in solid dispersions (SD). The data demonstrated that SA was able to improve the biopharmaceutical properties of the BCS II drug telmisartan (TEL) of low solubility even using relative small drug:polymer ratio. A solid state grinding process was used to prepare the solid dispersions (SD) during 45 min. The SD were prepared in different proportions of drug and carrier of 1:1, 1:3, 1:5, 1:7 and 1:9 (mass/mass). DSC, XRPD, FTIR and Raman confirmed the presence of molecular interactions between TEL and the carrier. FTIR supports the presence of hydrogen bonds between TEL and the carrier. SD_1:5, SD_1 :7 and SD_1 :9 enhanced the dissolution rate of the drug releasing more than 80% of the drug in just 30 min (83%, 84% and 87%). The the t-test results demonstrated equal dissolution efficiency values for SD_1:7 and Micardis (R), however the similarity (f2) and difference (f1) fit factors showed that the SD and Micardis (R) are statistically different. The physical stability studies demonstrated that SD using sodium alginate as a carrier remained unchanged during the period of 90 days at room temperature, showing that the sodium alginate acts as a good anti plasticizer agent, preventing the drug recrystallization. (C) 2015 Elsevier Ltd. All rights reserved.
机译:固体分散技术是提高水溶性差的药物溶解速度的最有效方法,但是它取决于合适的载体选择。这项工作探索了将生物聚合物海藻酸钠(SA)用作固体分散体(SD)中潜在的载体的用途。数据表明,即使使用相对较小的药物:聚合物比率,SA仍可以改善低溶解度的BCS II药物替米沙坦(TEL)的生物药物特性。固态研磨过程用于在45分钟内制备固体分散体(SD)。 SD按1:1、1:3、1:5、1:7和1:9(质量/质量)的药物和载体的不同比例制备。 DSC,XRPD,FTIR和Raman证实了TEL和载体之间存在分子相互作用。 FTIR支持在TEL和载体之间存在氢键。 SD_1:5,SD_1:7和SD_1:9提高了药物的溶出度,仅在30分钟内释放了80%以上的药物(83%,84%和87%)。 t检验结果表明SD_1:7和Micardis(R)的溶出效率值相等,但是相似性(f2)和差异(f1)拟合因子表明SD和Micardis(R)在统计学上是不同的。物理稳定性研究表明,使用藻酸钠作为载体的SD在室温下90天期间保持不变,表明藻酸钠可作为一种良好的抗增塑剂,防止药物重结晶。 (C)2015 Elsevier Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号